Analyst Rating UpgradeBrady Corp (BRC) and Pactiv Evergreen (PTVE) upgraded to Buy mainly on opportunities for growth and still-attractive valuations.
Growth And Operational EfficiencyBrady Corp is leveraged to reshoring, increased manufacturing capex, and moves to rationalize lower-margin and lower-growth products.
Valuation And Financial StrategyPactiv Evergreen has an attractive valuation and is showing improved volume and margin upside, with further benefits from deleveraging efforts.